EphA2 mediates opening of the blood brain barrier in cerebral malaria
Description: The proposed research is relevant to public health because EphA2 is a completely novel target for an adjunc- tive therapy to limit breakdown of the blood brain barrier - a key event in cerebral malaria. This in turn has the potential to save the lives of >0.5 million children with life-threatening symptoms of this condition every year. Thus, the proposed research is relevant to the part of the NIH's mission that pertains to developing fundamen- tal knowledge that will help to reduce the burdens of human disease and disability.
Funding type: research
Funder scheme: R01
Start date: 2017-03-01
End date: 2023-02-28
Investigator: TRACEY JANE LAMB (lead)
Institution: University of Utah
Subfield: Neurology
Field: Neuroscience
Domain: Life Sciences
Funded outputs count: 5
Funder award ID: R01NS097819
OpenAlex ID: G1925138688
